BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang X, Wu Z, Shen S, Niu Y, Guo Y, Liang J, Guo W. LINC01980 facilitates esophageal squamous cell carcinoma progression via regulation of miR-190a-5p/MYO5A pathway. Arch Biochem Biophys 2020;686:108371. [PMID: 32325088 DOI: 10.1016/j.abb.2020.108371] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Tang Y, Li C, Zhang YJ, Wu ZH. Ferroptosis-Related Long Non-Coding RNA signature predicts the prognosis of Head and neck squamous cell carcinoma. Int J Biol Sci 2021;17:702-11. [PMID: 33767582 DOI: 10.7150/ijbs.55552] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
2 Kong Q, Li G, Yin G, Li K, Zhang D, Xu W. Long Noncoding RNA WDFY3-AS2 Represses the Progression of Esophageal Cancer through miR-18a/PTEN Axis. J Oncol 2021;2021:9951010. [PMID: 34194502 DOI: 10.1155/2021/9951010] [Reference Citation Analysis]
3 Lv J, Zhang S, Liu Y, Li C, Guo T, Zhang S, Li Z, Jiao Z, Sun H, Zhang Y, Xu L. NR2F1-AS1/miR-190a/PHLDB2 Induces the Epithelial-Mesenchymal Transformation Process in Gastric Cancer by Promoting Phosphorylation of AKT3. Front Cell Dev Biol 2021;9:688949. [PMID: 34746118 DOI: 10.3389/fcell.2021.688949] [Reference Citation Analysis]
4 Liang X, Zha L, Yu G, Guo X, Qin C, Cheng A, Wang Z, Laudadio I. Construction and Comprehensive Prognostic Analysis of a Novel Immune-Related lncRNA Signature and Immune Landscape in Gastric Cancer. International Journal of Genomics 2022;2022:1-23. [DOI: 10.1155/2022/4105280] [Reference Citation Analysis]
5 Yan S, Xu J, Liu B, Ma L, Tan H, Fang C. Integrative bioinformatics analysis identifies LINC01614 as a potential prognostic signature in esophageal cancer. Transl Cancer Res 2021;10:1804-12. [PMID: 35116503 DOI: 10.21037/tcr-20-2529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang Y, Jia C, Kwoh CK. Predicting the interaction biomolecule types for lncRNA: an ensemble deep learning approach. Brief Bioinform 2021;22:bbaa228. [PMID: 33003205 DOI: 10.1093/bib/bbaa228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhao M, Cui H, Zhao B, Li M, Man H. Long intergenic non‑coding RNA LINC01232 contributes to esophageal squamous cell carcinoma progression by sequestering microRNA‑654‑3p and consequently promoting hepatoma‑derived growth factor expression. Int J Mol Med 2020;46:2007-18. [PMID: 33125097 DOI: 10.3892/ijmm.2020.4750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
8 Bhattacharjee S, Li J, Dashwood RH. Emerging crosstalk between long non-coding RNAs and Nrf2 signaling. Cancer Letters 2020;490:154-64. [DOI: 10.1016/j.canlet.2020.07.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
9 Raei N, Safaralizadeh R, Hesseinpourfeizi M, Yazdanbod A, Pourfarzi F, Latifi-Navid S. Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance. Life Sci 2021;284:119933. [PMID: 34508759 DOI: 10.1016/j.lfs.2021.119933] [Reference Citation Analysis]
10 Yang L, Lu P, Yang X, Li K, Chen X, Qu S. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Bioengineered 2021;12:12821-38. [PMID: 34898376 DOI: 10.1080/21655979.2021.2003925] [Reference Citation Analysis]
11 Zhou X, Zhuo M, Zhang Y, Shi E, Ma X, Li H. miR-190a-5p regulates cardiomyocytes response to ferroptosis via directly targeting GLS2. Biochem Biophys Res Commun 2021;566:9-15. [PMID: 34111670 DOI: 10.1016/j.bbrc.2021.05.100] [Reference Citation Analysis]
12 Yan S, Xu J, Liu B, Ma L, Feng H, Tan H, Fang C. Long non-coding RNA BCAR4 aggravated proliferation and migration in esophageal squamous cell carcinoma by negatively regulating p53/p21 signaling pathway. Bioengineered 2021;12:682-96. [PMID: 33602031 DOI: 10.1080/21655979.2021.1887645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yang C, Zheng X, Cao S. Identification of a Hypoxia-Related lncRNA Biomarker Signature for Head and Neck Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/6775496] [Reference Citation Analysis]